ID   M4Be 7GP122
AC   CVCL_8332
SY   7GP122; 7Gp122
DR   Wikidata; Q54605134
RX   PubMed=1503405;
RX   PubMed=8175891;
RX   PubMed=11059782;
CC   Characteristics: Highly metastatic.
CC   Doubling time: 30 +- 0.5 hours (PubMed=8175891).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8331 ! M4Be 7GP
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 10
//
RX   PubMed=1503405;
RA   Bailly M., Dore J.-F.;
RT   "Clonal drift and role of chromosome dosage in human melanoma
RT   metastatic cell lines: a statistical analysis.";
RL   Anticancer Res. 12:1163-1172(1992).
//
RX   PubMed=8175891; DOI=10.1002/jcb.240540205;
RA   Zebda N., Bailly M., Brown S., Dore J.-F., Berthier-Vergnes O.;
RT   "Expression of PNA-binding sites on specific glycoproteins by human
RT   melanoma cells is associated with a high metastatic potential.";
RL   J. Cell. Biochem. 54:161-173(1994).
//
RX   PubMed=11059782;
RA   Boukerche H., Baril P., Tabone E., Berard F., Sanhadji K., Balme B.,
RA   Wolf F., Perrot H., Thomas L.;
RT   "A new Mr 55,000 surface protein implicated in melanoma progression:
RT   association with a metastatic phenotype.";
RL   Cancer Res. 60:5848-5856(2000).
//